|
Name |
[(2R,3R,4S,5S)-4-acetyloxy-5-[(2,4-dioxopyrimidin-1-yl)methyl]-2-(hydroxymethyl)oxolan-3-yl] 2-hydroxy-4-methoxy-6-methylbenzoate
|
Molecular Formula | C21H24N2O10 | |
IUPAC Name* |
[(2R,3R,4S,5S)-4-acetyloxy-5-[(2,4-dioxopyrimidin-1-yl)methyl]-2-(hydroxymethyl)oxolan-3-yl] 2-hydroxy-4-methoxy-6-methylbenzoate
|
|
SMILES |
CC1=CC(=CC(=C1C(=O)O[C@@H]2[C@H](O[C@H]([C@@H]2OC(=O)C)CN3C=CC(=O)NC3=O)CO)O)OC
|
|
InChI |
InChI=1S/C21H24N2O10/c1-10-6-12(30-3)7-13(26)17(10)20(28)33-19-15(9-24)32-14(18(19)31-11(2)25)8-23-5-4-16(27)22-21(23)29/h4-7,14-15,18-19,24,26H,8-9H2,1-3H3,(H,22,27,29)/t14-,15+,18-,19+/m0/s1
|
|
InChIKey |
MMBHEUBJQPGITA-QGWWYQLQSA-N
|
|
Synonyms |
CHEMBL251438
|
|
CAS | NA | |
PubChem CID | 44445676 | |
ChEMBL ID | CHEMBL251438 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 464.4 | ALogp: | 0.4 |
HBD: | 3 | HBA: | 10 |
Rotatable Bonds: | 9 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 161.0 | Aromatic Rings: | 3 |
Heavy Atoms: | 33 | QED Weighted: | 0.472 |
Caco-2 Permeability: | -6.126 | MDCK Permeability: | 0.00003710 |
Pgp-inhibitor: | 0.012 | Pgp-substrate: | 0.017 |
Human Intestinal Absorption (HIA): | 0.975 | 20% Bioavailability (F20%): | 0.422 |
30% Bioavailability (F30%): | 0.994 |
Blood-Brain-Barrier Penetration (BBB): | 0.46 | Plasma Protein Binding (PPB): | 36.93% |
Volume Distribution (VD): | 0.339 | Fu: | 48.86% |
CYP1A2-inhibitor: | 0.055 | CYP1A2-substrate: | 0.087 |
CYP2C19-inhibitor: | 0.042 | CYP2C19-substrate: | 0.053 |
CYP2C9-inhibitor: | 0.026 | CYP2C9-substrate: | 0.179 |
CYP2D6-inhibitor: | 0.449 | CYP2D6-substrate: | 0.134 |
CYP3A4-inhibitor: | 0.202 | CYP3A4-substrate: | 0.134 |
Clearance (CL): | 8.228 | Half-life (T1/2): | 0.893 |
hERG Blockers: | 0.052 | Human Hepatotoxicity (H-HT): | 0.942 |
Drug-inuced Liver Injury (DILI): | 0.985 | AMES Toxicity: | 0.142 |
Rat Oral Acute Toxicity: | 0.023 | Maximum Recommended Daily Dose: | 0.021 |
Skin Sensitization: | 0.045 | Carcinogencity: | 0.307 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.011 |
Respiratory Toxicity: | 0.04 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005638 | 0.537 | D0OL7F | 0.416 | ||||
ENC005639 | 0.537 | D09SIK | 0.356 | ||||
ENC002576 | 0.536 | D0Y7DP | 0.295 | ||||
ENC003691 | 0.372 | D0J5TS | 0.277 | ||||
ENC005169 | 0.366 | D0D4YZ | 0.270 | ||||
ENC002972 | 0.348 | D0H0SJ | 0.264 | ||||
ENC002973 | 0.342 | D0CL9S | 0.248 | ||||
ENC003952 | 0.333 | D0Q0PR | 0.244 | ||||
ENC003805 | 0.325 | D0Z4PE | 0.243 | ||||
ENC003610 | 0.325 | D0OB1J | 0.239 |